Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients With Migraine: Results From Two Global Phase 3 Clinical Trials

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.04.1413

Related search